These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2277127)

  • 41. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of etretinate treatment on fluidity and lipid composition of the erythrocyte membrane in patients with psoriasis].
    Simonetti O; Messini L
    G Ital Dermatol Venereol; 1989; 124(11-12):493-7. PubMed ID: 2638642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of retinoids in the treatment of psoriasis.
    Warren EW; Khanderia U
    Clin Pharm; 1989 May; 8(5):344-51. PubMed ID: 2663325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.
    Schopf RE; Höcher J; Rehder M; Färber L; Morsches B
    Arch Dermatol Res; 1992; 284(4):227-31. PubMed ID: 1417069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Exfoliative cytology of psoriasis: effects of cyclosporin A].
    Altomare G; Tresoldi C; Schmitt EC; Fioroni A; Pigatto PD
    G Ital Dermatol Venereol; 1989; 124(7-8):325-8. PubMed ID: 2628276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of psoriasis. Results achieved by the Johannesburg Hospital Psoriasis Clinic.
    Sher MA; Sher B; Berro V
    S Afr Med J; 1986 Jan; 69(1):23-6. PubMed ID: 3941938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity.
    Górnicki A; Gutsze A
    Eur J Pharmacol; 2001 Jul; 423(2-3):127-34. PubMed ID: 11448476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and drug interactions of etretinate and acitretin.
    Lambert WE; Meyer E; De Leenheer AP; De Bersaques J; Kint AH
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S19-22. PubMed ID: 1460119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of etretinate on fibronectin in psoriatic skin.
    Lauharanta J; Salo O; Kanerva L; Lassus A
    Acta Derm Venereol; 1982; 62(4):358-61. PubMed ID: 6183879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of small doses of methotrexate in patients with psoriasis.
    Kamel RS; al-Hakiem MH; Rademaker M; Meyrick Thomas RH; Munro DD
    Acta Derm Venereol; 1988; 68(3):267-70. PubMed ID: 2455425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis.
    Zachariae H
    Arch Dermatol; 1984 Feb; 120(2):155. PubMed ID: 6696467
    [No Abstract]   [Full Text] [Related]  

  • 54. Etretinate increases carcinoembryonic antigen in palmar scrapings.
    Penneys NS; Taylor R; Hernandez D
    J Am Acad Dermatol; 1992 Jun; 26(6):940-2. PubMed ID: 1607412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
    Gordon KB; Ruderman EM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human in vivo phosphorus 31 magnetic resonance spectroscopy of psoriasis. A noninvasive tool to monitor response to treatment and to study pathophysiology of the disease.
    Zemtsov A; Dixon L; Cameron G
    J Am Acad Dermatol; 1994 Jun; 30(6):959-65. PubMed ID: 8188887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis.
    Ellis CN; Gold RC; Grekin RC; Anderson TF; Swanson NA; Voorhees JJ
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):699-704. PubMed ID: 7068978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy.
    Seppälä J; Laulainen M; Reunala T
    Clin Rheumatol; 1988 Dec; 7(4):498-503. PubMed ID: 3149925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.